Biosensors   

Is Biosensors a good buy?

Lock in some profit at 0.87-0.885.. still holding another 150 lots.

Managed to cover my contra losses accumulated from the recent sell down.. 

Thank you Biosensors.

I will be back.

 

thx gbleng, will Q @ 0.90 again.

WeiQiQi      ( Date: 02-Feb-2010 10:02) Posted: CS... not always conservation. I vague remember they issued a 'blue sky scenario' TP for Genting at $3!! That caused a stir after issuance. (or is it by another house)   gbleng      ( Date: 02-Feb-2010 07:53) Posted: CS has always been conservative in its tp.... but I think the price will not breech the .90 level until further news....

 

CS TP is realistic only in  the immediate term. But if you look at the potential of the JWMS and the approval of other markets like Japan, China etc the 1.23 by Nomura is definitely achieveable by mid-term.

 

CS... not always conservation. I vague remember they issued a 'blue sky scenario' TP for Genting at $3!! That caused a stir after issuance. (or is it by another house)

 

gbleng      ( Date: 02-Feb-2010 07:53) Posted: CS has always been conservative in its tp.... but I think the price will not breech the .90 level until further news..... WeiQiQi      ( Date: 01-Feb-2010 17:40) Posted: credit suisse overweights Biosenses tp 0.90 (this one is more achievable!!! than 1.23  :-)) 0707 GMT [Dow Jones] STOCK CALL: Credit Suisse raises Biosensors (B20.SG) target price to S$0.90 from S$0.80, based on discounted cashflow valuation, to reflect heart stent maker''s 3Q10 results, management''s guidance for stronger revenue in FY ended March 2011. 3Q10 net profit at US$12.4 million vs US$262,000 loss year earlier on higher sales of its flagship BioMatrix stent. Expects management''s target of 40% rise in FY11 revenue to be achievable, supported by recently-secured regulatory approval to sell BioMatrix in new markets France, Hong Kong, South Korea. Keeps Outperform call. Still, tips business in China to be challenging given Beijing''s recent guidelines on reforms to pricing mechanism for drugs, medical services; "the pricing of implanted medical supplies will be further regulated. We believe this creates uncertainties on stent pricing in the China market in 2010". Stock +6.3% at S$0.85. (FKH)

 

I'm hoping it will break out of 0.90, but hope springs eternal where BIG is concerned.  Where's the news??

 

This is because credit suisse dun have  Biosenses share.

 

CS has always been conservative in its tp.... but I think the price will not breech the .90 level until further news.....

WeiQiQi      ( Date: 01-Feb-2010 17:40) Posted: credit suisse overweights Biosenses tp 0.90 (this one is more achievable!!! than 1.23  :-)) 0707 GMT [Dow Jones] STOCK CALL: Credit Suisse raises Biosensors (B20.SG) target price to S$0.90 from S$0.80, based on discounted cashflow valuation, to reflect heart stent maker''s 3Q10 results, management''s guidance for stronger revenue in FY ended March 2011. 3Q10 net profit at US$12.4 million vs US$262,000 loss year earlier on higher sales of its flagship BioMatrix stent. Expects management''s target of 40% rise in FY11 revenue to be achievable, supported by recently-secured regulatory approval to sell BioMatrix in new markets France, Hong Kong, South Korea. Keeps Outperform call. Still, tips business in China to be challenging given Beijing''s recent guidelines on reforms to pricing mechanism for drugs, medical services; "the pricing of implanted medical supplies will be further regulated. We believe this creates uncertainties on stent pricing in the China market in 2010". Stock +6.3% at S$0.85. (FKH)

 

credit suisse overweights Biosenses tp 0.90 (this one is more achievable!!! than 1.23  :-))

0707 GMT [Dow Jones] STOCK CALL: Credit Suisse raises Biosensors (B20.SG)
target price to S$0.90 from S$0.80, based on discounted cashflow valuation,
to reflect heart stent maker''s 3Q10 results, management''s guidance for
stronger revenue in FY ended March 2011. 3Q10 net profit at US$12.4 million
vs US$262,000 loss year earlier on higher sales of its flagship BioMatrix
stent. Expects management''s target of 40% rise in FY11 revenue to be
achievable, supported by recently-secured regulatory approval to sell
BioMatrix in new markets France, Hong Kong, South Korea. Keeps Outperform
call. Still, tips business in China to be challenging given Beijing''s
recent guidelines on reforms to pricing mechanism for drugs, medical
services; "the pricing of implanted medical supplies will be further
regulated. We believe this creates uncertainties on stent pricing in the
China market in 2010". Stock +6.3% at S$0.85. (FKH)

 

O.O !!! TP of 1.23? Serious boh?

If can go above 0.9 really happy liao

AK_Francis      ( Date: 01-Feb-2010 16:51) Posted: Ha ha, big wok, Sell In Strength? Selling 10 ranging fr 0.835-0.85, for coming CNY Ang Bao. Ho ho, it climbed to 0.87 just now. OK lah, now soften liao, not so heart pain liao. Will not sell anymore liao, wait for sifu TP of 1.23. Cheers.

 

Ha ha, big wok, Sell In Strength? Selling 10 ranging fr 0.835-0.85, for coming CNY Ang Bao. Ho ho, it climbed to 0.87 just now. OK lah, now soften liao, not so heart pain liao. Will not sell anymore liao, wait for sifu TP of 1.23. Cheers.

 

0.85 taken down... Good work.

Now going towards 0.90 again.

novicealex      ( Date: 01-Feb-2010 14:56) Posted: no more ammo liao... Maybe you can do it for the benefit of the investors here. crimson      ( Date: 01-Feb-2010 14:53) Posted: Large sell Q at 0.85... let's break thru it... chiong for 0.87!!

 

no more ammo liao...

Maybe you can do it for the benefit of the investors here.

crimson      ( Date: 01-Feb-2010 14:53) Posted: Large sell Q at 0.85... let's break thru it... chiong for 0.87!!! novicealex      ( Date: 01-Feb-2010 14:44) Posted: Ok... trigger. Loaded another 30 @0.84.. Let's take the ride now..

 

Large sell Q at 0.85... let's break thru it... chiong for 0.87!!!

novicealex      ( Date: 01-Feb-2010 14:44) Posted: Ok... trigger. Loaded another 30 @0.84.. Let's take the ride now.. novicealex      ( Date: 01-Feb-2010 12:37) Posted: got another 10 lots @ 0.835 from Hse 5. Looks like we can see 0.84 after lunch if the HK recover by then. Ready for more at 0.84

 

Ok... trigger.

Loaded another 30 @0.84..

Let's take the ride now..

novicealex      ( Date: 01-Feb-2010 12:37) Posted: got another 10 lots @ 0.835 from Hse 5. Looks like we can see 0.84 after lunch if the HK recover by then. Ready for more at 0.84

 

 

BUY:    Biosensors

Closing price on 29 Jan S$0.80

Price target S$1.23

(from S$1.10)

Upside/downside 53.7%

Difference from consensus 43.0%

FY11F net profit (US$mn) 44.25

Difference from consensus na

Source: Nomura

Nomura vs consensus

We believe consensus has yet to

recognize the value of Biosensors’

50% stake in JWMS – one of the

three dominant local DES suppliers in China

 

got another 10 lots @ 0.835 from Hse 5.

Looks like we can see 0.84 after lunch if the HK recover by then.

Ready for more at 0.84

 

got another 10 lots at 0.83 from Hse 5.

 

Just remember, nobody can know where is the bottom.

If you believe their TP, then it is not consider late.  I loaded some more at 0.815.. and will load more if 0.84 breaks on 10,000 volume

crimson      ( Date: 01-Feb-2010 11:03) Posted: wah lau eh, missed the train on friday to buy in... sianz allright      ( Date: 01-Feb-2010 08:20) Posted: *DJ Biosensors Target Raised To S$1.23 From S$1.10 By Nomura (2010/02/01 08:05AM) Does anyone have any details? Just got the headlines from my broker

 

wah lau eh, missed the train on friday to buy in... sianz

allright      ( Date: 01-Feb-2010 08:20) Posted: *DJ Biosensors Target Raised To S$1.23 From S$1.10 By Nomura (2010/02/01 08:05AM) Does anyone have any details? Just got the headlines from my broker

 

The headlines is sufficient.  

Looks like it is taking effect.  With market still trending downwards, Biosensors is able to niche up.

Looking to add position if breaks 0.84 on high volume.

vested interest.